Effect of Whole-Body Cryotherapy on Iron Status and Biomarkers of Neuroplasticity in Multiple Sclerosis Women

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2022 Sep 23

PMID 36141293

Authors

Bartlomiej Ptaszek

Szymon Podsiadlo

Olga Czerwinska-Ledwig

Marcin Maciejczyk

Aneta Teleglow

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to compare the effect of a series of 20 whole body cryotherapy (WBC) sessions on iron levels and neuroplasticity biomarkers in women with multiple sclerosis (MS) and healthy women. Consent was obtained from the Bioethics Committee at the Regional Medical Chamber in Krakow (87/KBL/OIL/2018; 8 May 2018). The study was registered in the Australian New Zealand Clinical Trials Registry (ACTRN12620001142921; 2 November 2020). The study included 30 people: 15 women with multiple sclerosis (mean age 41.53 ± 6.98 years) and 15 healthy women (mean age 38.47 ± 6.0 years). Both groups attended cryotherapy sessions. Venous blood was collected for analysis before the WBC session and after 20 sessions. In women with MS and healthy women, no significant effect of WBC on changes in the level biomarkers of neuroplasticity was found. There were also no statistically significant differences between the groups of the analyzed indices at the beginning of the study.

Citing Articles

Whole-Body Cryostimulation in Multiple Sclerosis: A Scoping Review.

Alito A, Fontana J, Franzini Tibaldeo E, Verme F, Pitera P, Miller E J Clin Med. 2024; 13(7).

PMID: 38610768 PMC: 11012586. DOI: 10.3390/jcm13072003.

Effect of Whole-Body Cryotherapy on Oxidant-Antioxidant Imbalance in Women with Multiple Sclerosis.

Ptaszek B, Podsiadlo S, Adamiak J, Marchewka J, Tota L, Teleglow A J Clin Med. 2023; 12(18).

PMID: 37762899 PMC: 10532046. DOI: 10.3390/jcm12185958.

References

Lombardi G, Ziemann E, Banfi G . Whole-Body Cryotherapy in Athletes: From Therapy to Stimulation. An Updated Review of the Literature. Front Physiol. 2017; 8:258. PMC: 5411446. DOI: 10.3389/fphys.2017.00258. View

Dendrou C, Fugger L, Friese M . Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015; 15(9):545-58. DOI: 10.1038/nri3871. View

Olsson A, Gustavsen S, Gisselo Lauridsen K, Chenoufi Hasselbalch I, Sellebjerg F, Bach Sondergaard H . Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review. Acta Neurol Scand. 2021; 143(6):577-586. DOI: 10.1111/ane.13401. View

Hurrell R, Egli I . Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010; 91(5):1461S-1467S. DOI: 10.3945/ajcn.2010.28674F. View

Ramagopalan S, Sadovnick A . Epidemiology of multiple sclerosis. Neurol Clin. 2011; 29(2):207-17. DOI: 10.1016/j.ncl.2010.12.010. View

Cholewka A, Stanek A, Sieron A, Drzazga Z . Thermography study of skin response due to whole-body cryotherapy. Skin Res Technol. 2011; 18(2):180-7. DOI: 10.1111/j.1600-0846.2011.00550.x. View

Weiner H . Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol. 2004; 61(10):1613-5. DOI: 10.1001/archneur.61.10.1613. View

Stankiewicz J, Panter S, Neema M, Arora A, Batt C, Bakshi R . Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007; 4(3):371-86. PMC: 1963417. DOI: 10.1016/j.nurt.2007.05.006. View

Wilczak N, Schaaf M, Bredewold R, Streefland C, Teelken A, De Keyser J . Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis. Neurosci Lett. 1998; 257(3):168-70. DOI: 10.1016/s0304-3940(98)00829-5. View

10.

Zembron-Lacny A, Morawin B, Wawrzyniak-Gramacka E, Gramacki J, Jarmuzek P, Kotlega D . Multiple Cryotherapy Attenuates Oxi-Inflammatory Response Following Skeletal Muscle Injury. Int J Environ Res Public Health. 2020; 17(21). PMC: 7663269. DOI: 10.3390/ijerph17217855. View

11.

Balogh E, Paragh G, Jeney V . Influence of Iron on Bone Homeostasis. Pharmaceuticals (Basel). 2018; 11(4). PMC: 6316285. DOI: 10.3390/ph11040107. View

12.

Mori F, Nicoletti C, Rossi S, Motta C, Kusayanagi H, Bergami A . Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. Neuromolecular Med. 2014; 16(2):490-8. DOI: 10.1007/s12017-014-8297-7. View

13.

Acosta C, Cortes C, MacPhee H, Namaka M . Exploring the role of nerve growth factor in multiple sclerosis: implications in myelin repair. CNS Neurol Disord Drug Targets. 2013; 12(8):1242-56. DOI: 10.2174/18715273113129990087. View

14.

Forte G, Visconti A, Santucci S, Ghazaryan A, Figa-Talamanca L, Cannoni S . Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann Ist Super Sanita. 2005; 41(2):213-6. View

15.

Frota E, Rodrigues D, Donadi E, Brum D, Maciel D, Teixeira A . Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neurosci Lett. 2009; 460(2):130-2. DOI: 10.1016/j.neulet.2009.05.057. View

16.

Mori F, Rossi S, Piccinin S, Motta C, Mango D, Kusayanagi H . Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. J Neurosci. 2013; 33(49):19112-9. PMC: 6618776. DOI: 10.1523/JNEUROSCI.2536-13.2013. View

17.

Sarchielli P, Greco L, Stipa A, Floridi A, Gallai V . Brain-derived neurotrophic factor in patients with multiple sclerosis. J Neuroimmunol. 2002; 132(1-2):180-8. DOI: 10.1016/s0165-5728(02)00319-3. View

18.

Herz J, Reitmeir R, Hagen S, Reinboth B, Guo Z, Zechariah A . Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol Dis. 2011; 45(3):1077-85. PMC: 4578250. DOI: 10.1016/j.nbd.2011.12.026. View

19.

Bazhenov I, Filippova E, Bazarnyi V, Sazonov S, Volkova L, Zaitseva L . [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis]. Urologiia. 2018; (3):44-48. View

20.

Ferreira K, Oliveira S, Kallaur A, Kaimen-Maciel D, Lozovoy M, Regina Delicato de Almeida E . Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis. J Neurol Sci. 2017; 373:236-241. DOI: 10.1016/j.jns.2016.12.039. View